Literature DB >> 3029281

Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice.

J K Fazakerley, H E Webb.   

Abstract

Adoptive transfer experiments in athymic nude mice demonstrated that the demyelination seen in the central nervous system (CNS) following Semliki Forest virus (SFV) infection was directly dependent upon sensitized T lymphocytes. Antibodies generated during the infection did not seem to be involved in the demyelination, but thymus-dependent antibodies (IgG) were responsible for the reduction of brain virus titres. In the absence of a T cell response and T cell-dependent antibody production, virus persisted in the CNS for several months. Despite persistence of high virus titres for this time, only mice eventually developing a CNS inflammatory response developed lesions of demyelination. In the absence of an inflammatory response no demyelination was apparent even after several months of persistent infection. Administration of anti-SFV hyperimmune serum intracerebrally to both infected and control mice did not produce demyelination but resulted in CNS tissue degeneration with marked pycnosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029281     DOI: 10.1099/0022-1317-68-2-377

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  A single amino acid change in the nuclear localization sequence of the nsP2 protein affects the neurovirulence of Semliki Forest virus.

Authors:  John K Fazakerley; Amanda Boyd; Marja L Mikkola; Leevi Kääriäinen
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  bcl-2 acts early to restrict Semliki Forest virus replication and delays virus-induced programmed cell death.

Authors:  M F Scallan; T E Allsopp; J K Fazakerley
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

4.  Identification of immunoglobulin-containing cells in the central nervous system of the mouse following infection with the demyelinating strain of Semliki Forest virus.

Authors:  L M Parsons; H E Webb
Journal:  Br J Exp Pathol       Date:  1989-06

5.  Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.

Authors:  P B Challoner; K T Smith; J D Parker; D L MacLeod; S N Coulter; T M Rose; E R Schultz; J L Bennett; R L Garber; M Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

6.  In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection.

Authors:  I Subak-Sharpe; H Dyson; J Fazakerley
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 7.  Insights into Antibody-Mediated Alphavirus Immunity and Vaccine Development Landscape.

Authors:  Anthony Torres-Ruesta; Rhonda Sin-Ling Chee; Lisa F P Ng
Journal:  Microorganisms       Date:  2021-04-22

8.  Following Acute Encephalitis, Semliki Forest Virus is Undetectable in the Brain by Infectivity Assays but Functional Virus RNA Capable of Generating Infectious Virus Persists for Life.

Authors:  Rennos Fragkoudis; Catherine M Dixon-Ballany; Adrian K Zagrajek; Lukasz Kedzierski; John K Fazakerley
Journal:  Viruses       Date:  2018-05-18       Impact factor: 5.048

Review 9.  Analysis of the molecular basis of neuropathogenesis of RNA viruses in experimental animals: relevance for human disease?

Authors:  G J Atkins; I M Balluz; G M Glasgow; M J Mabruk; V A Natale; J M Smyth; B J Sheahan
Journal:  Neuropathol Appl Neurobiol       Date:  1994-04       Impact factor: 8.090

Review 10.  Pathogenesis of virus-induced demyelination.

Authors:  J K Fazakerley; M J Buchmeier
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.